Linares CLP, Linares CLB, Vitón CAA

Language: Spanish
References: 18
Page: 16-20
PDF size: 167.23 Kb.

ABSTRACT

Objective: to determine the behavior of adherence to pharmacological treatment in hypertensive elderly. Methods: analytical and cross-sectional study carried out on hypertensive older adults assigned to the Pedro Borras Astorga Teaching Polyclinic, in Pinar del Río, during 2018. The study of the individual and family health history, and the application of instruments in the 298 individuals that conformed the sample allowed the collection of information related to the studied variables, the tests χ² and Kruskal Wallis were used to determine association between them. Results: 25.2% of the participants belonged to the age group 65-69 years, women were the most representative patients. The average was ten years of disease evolution (6-14.5), 52.7% showed polypharmacy, 89.6% attended consultations occasionally. Age, gender, marital status, cohabitation, schooling, time of disease progression, presence of polypharmacy, consultation attendance, and level of knowledge showed a statistically significant association (p‹0.05) with drug adherence. Conclusion: It was determined the behavior of adherence, and its association with sociodemographic variables and others linked to the patient’s condition was identified. This will make possible to design new strategies at the Primary Care level to improve the disease control and reduce morbidity and mortality figures in order to improve the patient’s quality of life.

REFERENCES

1. Saqlain M, Riaz A, Malik MN, Khan S, Ahmed A, Kamran S, et al. Medication Adherence and Its Association with Health Literacy and Performance in Activities of Daily Livings among Elderly Hypertensive Patients in Islamabad, Pakistan. Medicina. 2019;55(5):163.

2. Nieto Poveda EC. Adherencia al tratamiento de enfermedades crónicas en adultos mayores con hipertensión arterial y diabetes tipo 2. REDIIS. 2018;2:44-57.

3. Franco Bonal A, Silva Valido JA, Soto Martínez O, Franco Bonal A. Evaluación de adherencia terapéutica antihipertensiva en el adulto mayor. Rev. inf. cient. 2018;97(6):1124-1134.

4. Pan J, Wu L, Wang H, Lei T, Hu B, MSa, et al. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine. 2019;98(27):e16116.

5. Adeoye AM, Adebiyi AO, Adebayo OM, Owolabi MO. Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients. Nigerian Postgrad Med J. 2019;26(1):18-24.

6. López Vázquez SA, Chávez Vega R. Adherencia al tratamiento antihipertensivo en pacientes mayores de 60 años. Rev haban cienc méd. 2016;15(1):40-50.

7. Tan ST, Quek RYC, Haldane V, Koh JJK, Han EKL, Ong SE, et al. The social determinants of chronic disease management: perspectives of elderly patients with hypertension from low socioeconomic background in Singapore. International Journal for Equity in Health. 2019;18:1.

8. Noale M, Limongi F, Maggi S. Epidemiology of Cardiovascular Diseases in the Elderly. Adv Exp Med Biol. 2020;1216:29-38.

9. Van Der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication nonadherence: a systematic review. J Hum Hypertens. 2017;31:687-694.

10. Martínez de Murga García G, Sujo Sit M, Estévez Perera A. Adherencia farmacológica en pacientes hipertensos. Rev Cubana Med Gen Integr. 2020;36(1):e982.

11. Alejos García ML, Marco Pinto JM. Nivel de conocimiento sobre hipertensión arterial en pacientes hipertensos [Tesis]. Lima: Universidad Peruana Cayetano Heredia; 2017. [Internet] [Citado en 2020 Oct 31] Disponible en: http://repositorio.upch.edu. pe/bitstream/handle/upch/1007/Nivel_AlejosGarcia_ Mireylle.pdf?sequence=3&isAllowed=y

12. Al-Ruthia YS, Hong SH, Graff C, Kocak M, Solomon D, Nolly R. Examining the relationship between antihypertensive medication satisfaction and adherence in older patients. Res. Soc. Adm. Pharm. 2017;13(3):602-613.

13. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37- 55.

14. Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and metaanalysis. Medicine. 2017;96(4):e5641.

15. Walsh CA, Cahir C, Bennett KE. Association between adherence to antihypertensive medications and health outcomes in middle and older aged community dwelling adults; results from the Irish longitudinal study on ageing. Eur J Clin Pharmacol. 2019;75:1283-1292.

16. Chudiak A, Uchmanowicz I, Mazur G. Relation between cognitive impairment and treatment adherence in elderly hypertensive patients. Clin Interv Aging. 2018;13:1409-1418.

17. Gwadry-Sridhar FH, Manias E, Lal L, Salas M, Hughes DA, Ratzki-Leewing A, et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health. 2013;16(5):863-71.

18. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Arun Keepanasseril, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.